Tag:
Novartis
Latest Headlines
Latest Headlines
Online databases display cancer cells' sensitivities to drugs
Personalized cancer care received another shot in the arm this week when researchers published free online databases outlining potential cancer vulnerabilities to various drugs. The databases were
Novartis embraces 'smart pills' as some worry about intrusion
Last week, Novartis reportedly became the largest drug company to embrace "smart pills" by agreeing to pay California start-up firm Proteus Biomedical $24 million to acquire exclusive licenses and
Text messaging keeps Tanzanian clinics stocked with anti-malarials
We love stories like this: applications of a basic, low-cost mobile technology to address a serious health crisis in a region terribly short on resources. In this case, the technology is text
SPOTLIGHT: Pharmas focusing on pet psych meds
Did you ever think your dog could suffer from dementia, OCD or an anxiety disorder? Apparently, pharmaceutical giants like Pfizer, Eli Lilly and Novartis do. The drugmakers are dishing out human
ALSO NOTED: FDA sending fewer warning letters;IL law would limit what hospitals can charge uninsured patients; and much more...
> It looks like the FDA is sending out a lot fewer warning letters to potential violators of late. Officials say they're just changing emphasis, but critics suggest that th agency is slacking off.
ALSO NOTED: Wireless "white spaces" could disrupt care; MA hopes "medical homes" catch on; and much more...
> With telecommunications industry pressure mounting to put them to use, technology vendors and engineering groups are fighting what they say is a critical battle to protect so-called "white
ALSO NOTED: FDA may require side-effects hotline number in DTC ads; Many uninsured could be eligible for gov't insurance; and m
> An FDA panel is considering whether it should require direct-to-consumer advertisers to include a side-effects hotline in every commercial.
ALSO NOTED: FDA investigates Roche, Novartis transplant drugs; Maryland hospital fined for radiation errors; and much more...
> The FDA has started to investigate whether Roche's CellCept and Novartis' Myfortic, similar drugs used in transplants to prevent organ rejection, cause an often-fatal neurological disease.
